The Latest Cardiac and Vascular News
Mithril Capital-led Series C to launch 5-minute noninvasive ischemia assessment requiring no pharmaceuticals, no exercise, and no radiation. MASON, Ohio–(BUSINESS WIRE)–Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing. The round was led by Mithril Capital with participation from […]
Health care leader brings more than a decade of senior leadership experience and a track record of growth in serving hospitals and health systems. SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance management company, announced they have named Stephen Hiscott as Chief Growth Officer. Stephen comes to Biome from Premier, […]
McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about what drove him to CRG after a long tenure with Abbott.
New CEO appoints two new executives and promotes senior scientist to new Chief Medical Officer position to focus company and help drive delivery of long-term growth strategy Terry Burke joins Clario as Executive Vice President of Clario’s eCOA business and David Fusco as Executive Vice President of Human Capital Dr. Todd Rudo, M.D. is promoted […]
Kaiser Permanente Center for Thoracic Aortic Disease study confirms low long-term risk for most aneurysms OAKLAND, Calif., Oct. 5, 2022 /PRNewswire/ — A large, new Kaiser Permanente study provides high-quality evidence that most of the 33,000 patients diagnosed each year in the U.S. with a thoracic aortic aneurysm — a bulge in […]
MINNEAPOLIS, Oct. 5, 2022 /PRNewswire/ — VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that Dr. Ari Kramer, Assistant Professor, Department of Surgery and Director, Vascular Access Program, Spartanburg Regional Healthcare […]
PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products that act directly on the brain to treat resistant/difficult to treat hypertension and heart-failure, today published its first half 2022 results. Jean-Philippe Milon, CEO […]
SAN DIEGO, Oct. 4, 2022 /PRNewswire/ — Starlight Cardiovascular announced today that it has closed the first $9.48M in an $11.45M Series A financing, which will be used to progress development of its portfolio of pediatric interventional cardiology devices. The financing is led by Bird B and included conversion of previously-issued notes. “Congenital Heart Defects are […]
CLEVELAND, Oct. 4, 2022 /PRNewswire/ — Centerline Biomedical, Inc. (“Centerline”), which recently commercialized its Intra-Operative Positioning Systems IOPS®, has appointed Gulam Khan, Chief Executive Officer. Mr. Khan has more than two decades of executive leadership experience, including serving as the President and CEO of Mentor, Ohio-based US Endoscopy and serving as the Senior Vice […]
ROCKVILLE, Md., Oct. 4, 2022 /PRNewswire/ — Adventist HealthCare Shady Grove Medical Center has earned national certification for mechanical thrombectomy, a minimally invasive surgical treatment for stroke that studies show can improve outcomes for many patients. Shady Grove Medical Center attained Thrombectomy-Capable Stroke Center (TSC) Certification from The Joint Commission, in collaboration with the […]
